Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

Colazide approved for ulcerative colitis maintenance in Europe

Sep. 17, 1999

Solvay scientists describe new motilin agonists derived from erythromycin

Sep. 16, 1999

rhIL-11 tested in active Crohn's disease

Sep. 16, 1999

XTL and Lilly to collaborate on HCV therapy research

Sep. 14, 1999

Isis and Abbott initiate collaboration for antisense drugs

Sep. 14, 1999

LEX-032, a recombinant serpin with beneficial effects on ischemia/reperfusion-induced pancreatitis

Sep. 13, 1999

New acylquinoline selected for development as antiulcer agent by Korean investigators

Sep. 13, 1999

Oxagen broadens collaboration in IBD research

Sep. 13, 1999

Synsorb Biotech searches for treatments for bacterial toxin-induced diseases

Sep. 13, 1999

New naturally occurring hepatoprotective/immunostimulating compound from Il Yang in phase II

Sep. 10, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 12, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...